#HVO hVIVO – H1 TRADING UPDATE July 22, 2025 – Posted in: Blog, hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, provides an unaudited trading update for the six months ended 30 June 2025 (H1 2025). Highlights · Revenue of £24.2 million (H1 2024: £35.6 million), in line with expectations of £47 million for the full year · EBITDA margin (pre-exceptionals) of c.12% (H1 2024: 24.5%) · Cash of £23.3 million as at 30 June 2025 (30 June…

#ORPH Open Orphan – Why scientists are deliberately infecting volunteers with Covid-19 September 16, 2021 – Posted in: Open Orphan (ORPH)

If you are going to catch covid-19, jokes Jacob Hopkins, a university student, the safest place to do it is in a hospital. So in March Mr Hopkins lay down on a bed in the Royal Free Hospital in London while doctors placed droplets of liquid carrying the sars–cov-2 virus into his nose. Mr Hopkins was one of 36 participants in the first “human challenge trial” (hct) for covid-19. Human trials are a valuable part of medical…

#HVO hVIVO – H1 TRADING UPDATE July 22, 2025 – Posted in: Blog, hVIVO (HVO)

#ORPH Open Orphan – Why scientists are deliberately infecting volunteers with Covid-19 September 16, 2021 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL